Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.

Proc Natl Acad Sci U S A · 2017 · PMC5724261 · PMID 29087320

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Examination of pTRAF2 in tumor xenografts revealed a decreasing trend in mice treated with both NOS2 and COX2 inhibitor ( Fig.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.